Fluorescence Probes Synthesis

Medicilon's fluorescent probes and labeling platforms can provide fluorescent probe design and synthesis services for scientific institutions, drug R&D companies, and other customers.

Design and synthesis steps

Fluorescent probes are tools used to detect, measure and analyze biomolecules, cells and tissues. They achieve these purposes by emitting and receiving fluorescent signals. Medicilon can complete the design and synthesis of fluorescent probes for biomolecules.
Selection of target molecules and determination of target.Selection of fluorescent dyes.Design of molecular structure.Synthesize probe molecules.Testing the properties of probe molecules.

Custom synthesis

Medicilon's fluorescent probes and labeling platforms can provide fluorescent probe design and synthesis services for scientific institutions, drug R&D companies, and other customers. After years of development, Medicilon's fluorescent probes and labeling platforms have accumulated rich experience in the synthesis of high-quality fluorescent (phosphorescent) dyes, luminescent materials, contrast agents, and their applications in novel and classical fluorescent probes. In addition, Medicilon also supports the upstream and downstream development of fluorescent biological probes, aiming to provide customers with a complete solutions for multiple biomarker studies in-vivo (in-vitro), and provide customers with multi-field and multi-level R&D service support.

Applications

Fluorescent probes are widely used in biomedicine, drug research and development, environmental monitoring, chemical analysis and other fields.
Cell imaging
Fluorescent probes can be used for live cell imaging. Through the use of fluorescent probes, fluorescent probes with different properties can be used to monitor the imaging cell status of different organelles and metabolic processes. This can be applied in monitoring important biochemical processes such as cell apoptosis and reactive oxygen species generation.
Drug screening
Fluorescent probes can be used for protein analysis, such as protein inhibition, activation, binding, etc. The function of the protein can be monitored by observing changes in fluorescence intensity to determine whether the drug interacts with the proteins, providing a basis for further drug development.
Drug development
Fluorescent probes are also widely used in drug research and development, including drug absorption, metabolism, and pharmacodynamics. The properties of drug absorption kinetics can be interpreted by observing changes in fluorescence signals, providing support for further drug development.

此博客中的热门博文

What is preclinical testing?

In the process of preclinical testing of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a preclinical research phase followed, before which, as described above, the potential toxicity of the compou

阅读全文

Inventory of the three major in vitro pharmacokinetic research methods

The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d

阅读全文

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati

阅读全文

Shanghai Medicilon Inc.

搜索此博客